These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2233518)

  • 1. Decrease in childhood neuroblastoma death in Japan.
    Hanawa Y; Sawada T; Tsunoda A
    Med Pediatr Oncol; 1990; 18(6):472-5. PubMed ID: 2233518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan.
    Suita S; Zaizen Y; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Ueda K; Tasaka H; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Yano H; Akiyama H; Ikeda K
    J Pediatr Surg; 1996 Apr; 31(4):555-8. PubMed ID: 8801312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of HPLC mass screening for neuroblastoma to a decrease in mortality.
    Nishi M; Takeda T; Hatae Y; Hanai J; Fujita K; Ichimiya H; Tanaka T
    J Exp Clin Cancer Res; 2002 Mar; 21(1):73-8. PubMed ID: 12071533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of high-risk pediatric neuroblastoma patients in a developing country.
    Easton JC; Gomez S; Asdahl PH; Conner JM; Fynn AB; Ruiz C; Ojha RP
    Pediatr Transplant; 2016 Sep; 20(6):825-30. PubMed ID: 27235336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma in childhood.
    DeLorimier AA; Bragg KU; Linden G
    Am J Dis Child; 1969 Sep; 118(3):441-50. PubMed ID: 5807651
    [No Abstract]   [Full Text] [Related]  

  • 6. Risks and benefits of ending of mass screening for neuroblastoma at 6 months of age in Japan.
    Tajiri T; Souzaki R; Kinoshita Y; Tanaka S; Koga Y; Suminoe A; Matsuzaki A; Hara T; Taguchi T
    J Pediatr Surg; 2009 Dec; 44(12):2253-7. PubMed ID: 20006005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of mass screening for neuroblastoma in infancy.
    Sawada T; Matsumura T; Kawakatsu H; Sugimoto T; Kuroda H; Hosoi H; Michihata T; Saida T; Hino T
    Am J Pediatr Hematol Oncol; 1991; 13(1):3-7. PubMed ID: 2029075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secular trends in neuroblastoma mortality before and after the cessation of national mass screening in Japan.
    Katanoda K; Hayashi K; Yamamoto K; Sobue T
    J Epidemiol; 2009; 19(5):266-70. PubMed ID: 19652443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma. Mass screening for early detection and its prognosis.
    Sawada T; Kidowaki T; Sakamoto I; Hashida T; Matsumura T; Nakagawa M; Kusunoki T
    Cancer; 1984 Jun; 53(12):2731-5. PubMed ID: 6722733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement in prognosis of neuroblastoma through mass population screening.
    Naito H; Sasaki M; Yamashiro K; Takeda T; Takasugi N; Uchino J; Hata Y
    J Pediatr Surg; 1990 Feb; 25(2):245-8. PubMed ID: 2303994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [NEUROBLASTOMA IN PEDIATRIC PATIENTS].
    Solovyov AE; Morgun VV; Paholchuk AP
    Klin Khir; 2015 Jun; (6):59-61. PubMed ID: 26521471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mass screening on age-specific incidence of neuroblastoma.
    Bessho F
    Int J Cancer; 1996 Aug; 67(4):520-2. PubMed ID: 8759611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-assisted image analysis can aid the prognostication of advanced-stage neuroblastomas.
    Mogilner JG; Eldar S; Sabo E; Hassoun M; Attias D; Brodski A; Ben Harush M; Kuten A; Steiner Z; Misselevich I; Bejar J; Ben Yizhak D; Kerner V; Laor R; Boss JH
    J Cancer Res Clin Oncol; 2000 May; 126(5):285-90. PubMed ID: 10815764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.
    Yamamoto K; Hayashi Y; Hanada R; Kikuchi A; Ichikawa M; Tanimura M; Yoshioka S
    J Clin Oncol; 1995 Aug; 13(8):2033-8. PubMed ID: 7636545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere biology in neuroblastoma: telomere binding proteins and alternative strengthening of telomeres.
    Onitake Y; Hiyama E; Kamei N; Yamaoka H; Sueda T; Hiyama K
    J Pediatr Surg; 2009 Dec; 44(12):2258-66. PubMed ID: 20006006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic factors in neuroblastoma in children].
    Blinov VM; Bukhny AF; Izrail'skaia MA; Dzhalalov KD
    Vopr Onkol; 1984; 30(5):21-31. PubMed ID: 6730411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is neuroblastoma screening evaluation needed and feasible?
    Estève J; Parker L; Roy P; Herrmann F; Duffy S; Frappaz D; Lasset C; Hill C; Sancho-Garnier H; Michaelis J
    Br J Cancer; 1995 Jun; 71(6):1125-31. PubMed ID: 7779698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the role of surgery in 25 patients with metastatic neuroblastoma].
    Nakadate H; Kishino T; Ogawa Y; Hatayama Y; Hatae Y; Takeda T; Naitoh H; Sasaki M
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1315-20. PubMed ID: 2369136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up status of patients with neuroblastoma after undergoing either aggressive surgery or chemotherapy--a single institutional study.
    Kubota M; Yagi M; Kanada S; Okuyama N; Kinoshita Y; Yamazaki S; Asami K; Ogawa A; Watanabe T
    J Pediatr Surg; 2004 Sep; 39(9):1328-32. PubMed ID: 15359385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.